Immunoproteasome modulating therapeutics to transform treatment of autoimmune and inflammatory diseases.
PI: Gang Lin, Ph.D. and Carl Nathan, M.D. of Weill Cornell Medicine
Immunoproteasome modulating therapeutics to transform treatment of autoimmune and inflammatory diseases.
PI: Gang Lin, Ph.D. and Carl Nathan, M.D. of Weill Cornell Medicine
© 2024 Research Bridge Partners. All rights reserved